Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In patients with primary aldosteronism (PA), long-term cardiovascular and mortality outcomes after adrenalectomy vs mineralocorticoid receptor antagonist (MRA) have not been compared yet. We aim to compare the clinical outcomes of these patients after treatment.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur J Endocrinol

Title: European journal of endocrinology

Publisher: Bioscientifica

ISSN (Electronic): 1479-683X

ISSN (Print): 0804-4643

Publication date (Electronic): Dec 01 2022

Volume: 187

Issue: 6

Affiliations

[1 ] School of Medicine, Chang Gung University, Taoyuan, Taiwan.

[2 ] Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.

[3 ] Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

[4 ] School of Medicine, National Yang-Ming University, Taipei, Taiwan.

[5 ] Department of Endocrinology, Changi General Hospital, SingHealth, Singapore.

[6 ] Department of Endocrinology, Singapore General Hospital, Singapore.

[7 ] Department of Urology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.

[8 ] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

[9 ] TAIPAI, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taiwan.

Article

DOI: 10.1530/EJE-22-0375

PubMed ID: 36315466

SO-VID: 4a133d31-f6ba-4d5c-8922-e8edc210ec05

History

Data availability:

Comments

Comment on this article

scite_

Cited by 7

See all cited by